Protein C and protein S deficiencies

Area of Science:

• Hematology
• Genetics
• Molecular Biology

Background:

• The protein C (PC) pathway, with its cofactor protein S (PS), is a critical endogenous antithrombotic system.
• Deficiencies in PC or PS are linked to an increased risk of thrombophilia (blood clotting disorders).

Purpose of the Study:

• To investigate the molecular basis and clinical implications of hereditary protein C and protein S deficiencies.
• To understand the heterogeneity of mutations and their impact on allele expression and thrombotic risk.

Main Methods:

• Analysis of mutation spectrum in hereditary PC and PS deficiencies.
• Correlation of genotype with clinical presentation and thrombotic events.
• Assessment of the influence of co-inherited genetic factors, such as Factor V Arg 506 to Gln mutation.

Main Results:

• Hereditary PC and PS deficiencies result from a wide array of mutations with diverse effects on gene expression.
• Homozygous or compound heterozygous mutations in the PC gene can lead to severe, early-onset thrombotic complications.
• Heterozygous individuals face a significant risk of recurrent adult thrombosis, with approximately 50% experiencing events by age 45.
• Co-inheritance of PC or PS defects with Factor V Arg 506 to Gln mutation occurs in 10-30% of symptomatic patients.

Conclusions:

• The clinical manifestation of hereditary PC and PS deficiencies is highly heterogeneous, influenced by the specific mutation and genetic background.
• Genetic factors, including mutations in PC and PS genes and other susceptibility genes, collectively determine thrombotic risk.
• Understanding these genetic underpinnings is crucial for managing patients with thrombophilia.